SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001600132-20-000070
Filing Date
2020-06-26
Accepted
2020-06-26 16:07:50
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 s-3june2020.htm S-3 447213
2 EXHIBIT 4.6 s-3june2020ex46.htm EX-4.6 438568
3 EXHIBIT 4.7 s-3june2020ex47.htm EX-4.7 394483
4 EXHIBIT 5.1 s-3june2020ex51.htm EX-5.1 42251
5 EXHIBIT 23.1 s-3june2020ex231.htm EX-23.1 3178
6 mintza02.jpg GRAPHIC 3698
  Complete submission text file 0001600132-20-000070.txt   1331975
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-239473 | Film No.: 20994210
SIC: 2834 Pharmaceutical Preparations